Foresite Capital Management IV, LLC
10% Owner
- 2026
- Feb 7, 2026
- 1
10% Owner
Latest filing:
Foresite Capital Management IV, LLC is 10% Owner of Eikon Therapeutics, Inc. (EIKN). 1 SEC Form 4 filing on record, dated 7 February 2026. Most recent open-market trade: bought $1000K of EIKN on 7 February 2026. Lifetime open-market purchases: $1000K.
The latest 15 SEC Form 4 transactions reported by Foresite Capital Management IV, LLC.
InsiderAlpha's records for Foresite Capital Management IV, LLC go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. The typical open-market purchase is $1000K (1 buy totaling $1000K). The largest single buy on record is $1000K of EIKN in 2026. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Insiders who reported open-market trades in the last 12 months at the companies Foresite Capital Management IV, LLC files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Browse nearby insider profiles in alphabetical order.
Foresite Capital Management IV, LLC is an investment firm, tracked as 10% Owner of Eikon Therapeutics, Inc. (EIKN). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
The only primary Form 4 on record is dated 7 February 2026.
Recorded transactions: 1 open-market purchase ($1000K) and 0 open-market sales across all tracked filings.